original ) (raw )Comparison of the VERSANT™ HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR™ hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy
Jeffrey Germer
Diagnostic Microbiology and Infectious Disease, 2003
View PDFchevron_right
Comparison of Qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and Quantitative (COBAS AMPLICOR HCV Monitor 2.0 versus VERSANT HCV RNA 3.0) Assays for Hepatitis C Virus (HCV) RNA Detection and Quantification: Impact on Diagnosis and Treatment of HCV Infections
Isabelle Desombere
Journal of Clinical Microbiology, 2005
View PDFchevron_right
Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study
Farah Bokharaei-Salim
Iranian Red Crescent Medical Journal
View PDFchevron_right
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice
Mitchell Shiffman
The American journal of gastroenterology, 2003
View PDFchevron_right
The assessment of serum hepatitis C virus RNA 12 weeks after the end of treatment using TaqMan polymerase chain reaction is less relevant than after 24 weeks for predicting sustained virological response
Osamu Yokosuka , Fumio Imazeki
Hepatology, 2011
View PDFchevron_right
Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b
Takashi Kumada
Journal of Clinical Virology, 2010
View PDFchevron_right
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy
J. Garaud
Journal of Viral Hepatitis, 2001
View PDFchevron_right
Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy
Pascale Trimoulet
Journal of Medical Virology, 2004
View PDFchevron_right
Quantification of Hepatitis C Virus RNA in a multicentre study : implication for the 1 management of HCV genotype 1 patients 2 3 Running title : Multicentre study for quantification of HCV RNA 4 5
Giulio Pisani
2009
View PDFchevron_right
Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response
Ola Weiland
Journal of Viral Hepatitis, 2005
View PDFchevron_right
First Week HCV RNA Level Under the Pegylated Interferon and Ribavirin Treatment Predicts Sustained Virological Response
Osman Özdoğan
American Journal of Therapeutics, 2016
View PDFchevron_right
Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
Hubert Niesters
Journal of Hepatology, 1999
View PDFchevron_right
Early Prediction of Hepatitis C Virus (HCV) Infection Relapse in Nonresponders to Primary Interferon Therapy by means of HCV RNA Whole-Blood Analysis
Markus Woegerbauer
Clinical Infectious Diseases, 2004
View PDFchevron_right
Abbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients
Masashi Mizokami
Journal of Clinical Microbiology, 2008
View PDFchevron_right
Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment
Percy Knolle
Archives of Virology, 1997
View PDFchevron_right
Real-Time PCR Assays for Hepatitis C Virus (HCV) RNA Quantitation Are Adequate for Clinical Management of Patients with Chronic HCV Infection
Hacène Khiri , Guillaume Pénaranda , Denis Ouzan
Journal of Clinical Microbiology, 2006
View PDFchevron_right
Quantification of Hepatitis C Virus (HCV) RNA in a Multicenter Study: Implications for Management of HCV Genotype 1-Infected Patients
Francesco Marino , Maria Wirz , Francesca Luciani , Giulio Pisani
Journal of Clinical Microbiology, 2009
View PDFchevron_right
Presence of HCV RNA in peripheral blood mononuclear cells may predict patients response to interferon and ribavirin therapy
Nasib Zaman
Annals of Saudi medicine
View PDFchevron_right
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-a therapy
Kiwamu Okita
Digest Dis Sci, 1995
View PDFchevron_right
The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy
Inmaculada Castillo
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy
Kiwamu Okita
Digestive Diseases and Sciences, 1995
View PDFchevron_right
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
Rishikant Kandikonda
…, 2002
View PDFchevron_right
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
Takashi Kumada , Koichi Takaguchi , Noritomo Shimada
BMC Infectious Diseases, 2012
View PDFchevron_right
Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy
Danuta Januszkiewicz-lewandowska
Japanese journal of infectious diseases, 2007
View PDFchevron_right
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Lubbertus Baak
Journal of Viral Hepatitis, 2009
View PDFchevron_right